The Claim
Chemogenetic or optogenetic activation of the medial amygdala–ventromedial hypothalamus circuit increases hepatic gluconeogenic gene expression (e.g., G6pc, Foxo1) and pyruvate-to-glucose conversion without altering liver glycogen content in unstressed mice.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When scientists turn on a specific brain circuit in mice that connects fear and stress areas to the metabolism control center, the liver starts making more sugar from scratch—even though the stored sugar in the liver doesn’t change.
See the scientific wording
Chemogenetic or optogenetic activation of the medial amygdala–ventromedial hypothalamus circuit increases hepatic gluconeogenic gene expression (e.g., G6pc, Foxo1) and pyruvate-to-glucose conversion without altering liver glycogen content in unstressed mice.
What the research says
1 studyStudy: Amygdala–liver signalling orchestrates glycaemic responses to stress
When mice are stressed, a brain circuit connected to the liver tells it to make more sugar from scratch—without touching stored sugar—and this is exactly what the claim says happens when you artificially turn on that same brain circuit.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.